Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Fumagillin-Derived Polymer Conjugate XMT-1107

Known as: XMT-1107 
A polymeric prodrug consisting of the fumagillol-derived small molecule XMT-1191 tethered to the hydrophilic, biodegradable70 kDa polymer poly[1… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
2526 Background: Fumagillol derivatives are novel anti-angiogenic agents that inhibit methionine aminopeptidase 2 (MetAP2) rather… Expand
Is this relevant?
2010
2010
XMT-1107 is a novel polymer fumagillol derivative, comprised of the small molecule XMT-1191 conjugated to a 70 kDa biodegradable… Expand
Is this relevant?
2010
2010
Teva Pharmaceutical Industries has entered into an agreement with Mersana Therapeutics for rights to develop and commercialize… Expand
Is this relevant?
2009
2009
XMT-1107, a fumagillin-derived polymer conjugate, and XMT-1191, the in vivo release product of XMT-1107, were evaluated for (1… Expand
Is this relevant?
2009
2009
XMT-1107 is a novel polymer fumagillol derivative, comprised of the small molecule XMT-1191 conjugated to a 70 kDa biodegradable… Expand
Is this relevant?